Valuation: Alcon

Market Cap 35.16B 30.17B 28.31B 25.87B 48.79B 3,355B 49.01B 335B 130B 1,692B 132B 129B 5,600B P/E 2026 *
43.5x
P/E 2027 * 26.4x
Enterprise Value 37.71B 32.36B 30.36B 27.74B 52.32B 3,597B 52.55B 359B 139B 1,814B 142B 138B 6,006B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 3.11x
Free-Float
97.34%
Yield 2026 *
0.51%
Yield 2027 * 0.57%
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 35.35B
+0.03%-2.87%-40.86%-8.53% 85.36B
-0.20%-2.88%-10.51%-20.42% 35.35B
-0.49%-4.07%-1.09%-21.72% 14.25B
-1.34%+1.18% - - 11.96B
-0.76%+9.74%-10.58%+743.48% 2.78B
+2.33%-2.66%-42.86%-56.92% 1.46B
+1.78%+3.04%+16.95%+10.70% 897M
-0.58%-1.30%+51.48%-8.18% 890M
+0.15%+3.10% - - 890M
Average +0.09%+1.03%-5.35%+91.20% 17.09B
Weighted average by Cap. -0.13%-1.61%-27.70%+1.59%

Financials

2026 *2027 *
Net sales 11.09B 9.52B 8.93B 8.16B 15.39B 1,058B 15.45B 106B 40.99B 534B 41.63B 40.73B 1,766B 11.77B 10.1B 9.48B 8.66B 16.34B 1,123B 16.41B 112B 43.52B 567B 44.2B 43.24B 1,875B
Net income 764M 656M 615M 562M 1.06B 72.91B 1.07B 7.27B 2.82B 36.77B 2.87B 2.81B 122B 1.26B 1.08B 1.01B 926M 1.75B 120B 1.75B 11.98B 4.65B 60.57B 4.73B 4.62B 201B
Net Debt 2.54B 2.18B 2.05B 1.87B 3.53B 243B 3.55B 24.22B 9.41B 122B 9.55B 9.35B 405B 1.45B 1.24B 1.17B 1.07B 2.01B 138B 2.02B 13.8B 5.36B 69.77B 5.44B 5.33B 231B
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA